| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.34 | 7e-07 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 8e-07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0004 |